PULMONER EMBOLİ 2019

Öz

Pulmoner emboli (PE) yüksek mortaliteye sahip olan ve acil servislerde sık şüphelenilen olgulardan biridir. Acil servislerde şüphe/tanı oranı düşük ama mortalitesi yüksektir. Nonspesifik klinik bulgular ve geniş spektrumda semptoma sahip olduğundan dolayı tanısı zordur. Klinik tecrübeye bağlı yargı, klinik tahmin skorlama sistemleri, dışlama kriterleri ve D-dimer testi tanının dışlanmasında önemlidir. Transtorasik ekokardiyografi ve bilgisayarlı tomografi pulmoner anjiyografi (BTPA) özellikle hemodinamik instabil olgularda hızlı tanıda önemlidir. Ventilasyon/Perfüzyon sintigrafisi BTPA çekilemeyen ve radyasyondan kaçınmak istediğimiz hastalarda faydalıdır. PE’ erken risk sınıflaması ve instabil hastalarda hızlı reperfüzyon tedavisi hayat kurtarıcıdır. Bu derlemede acil servisin kırmızı bayraklarında olan PE’ nin tanı ve tedavisi hakkında European Respiratory Society (ERS) 2019 PE klavuzu eşliğinde bilgiler verilmiştir.

Anahtar Kelimeler

• Pulmoner emboli,Hemodinamik instabilite

PULMONARY EMBOLISM 2019

Öz

Pulmonary embolism (PE) is one of the most suspected cases in the emergency department with high mortality. The suspicion/diagnosis ratio is low in emergency departments but itsmortality is high. Diagnosis of PE is difficult because it has nonspecific clinical findings and a broad spectrum of symptoms. Judgment based on clinical experience, prediction rules, exclusion criteria, and D-dimer test are important in excluding the diagnosis. Transthoracic echocardiography and computed tomography pulmonary angiography (CTPA) are important in rapid diagnosis, especially in patients with hemodynamic instability. Ventilation / Perfusion scintigraphy is useful in patients who cannot receive BTPA and want to avoid radiation. Early risk classification of PE and rapid reperfusion therapy in unstable patients are life-saving. In this review, information about the diagnosis and management of PE, which is one of the red flags of the emergency department, is provided by the European Respiratory Society (ERS) 2019 guideline for PE.

Anahtar Kelimeler

• Pulmonary embolism,Hemodynamic instability

Kaynakça

1. 1. Raskob GE, Angchaisuksiri P, Blanco AN, et al. for the ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71.
2. 2. Wendelboe AM, McCumber M, Hylek EM, et al. for the ISTH Steering Committee for World Thrombosis Day. Global public awareness of venous thromboembolism. J Thromb Haemost 2015;13:1365-71.
3. 3. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016;118:1340-1347.
4. 4. Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-764.
5. 5. Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost 2016;42(8): 808–820. DOI:10.1055/s-0036-1592333.
6. 6. Arseven O, Sevinç C, Ekim N, et al. Pulmoner Tromboembolism Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Derneği, 2015.
7. 7. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism Circulation 2003;107:I9 I16.
8. 8. Yılmaz S, Topçu F, Selimoğlu Şen H, Abakay Ö, Yılmaz Z. Pulmoner emboli tanısında Wells klinik skorlaması ile yüksek D-dimer seviyesinin kombinasyonu. Journal Clinical and Experimental Investigations 2014;5(4):557-562.

9. 9. Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000;48:23-33.
10. 10. Konstantinides SV, Meyer G, Becattini C et al. 2019 Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal 2019;00:1-61 DOI:10.1093/eurheartj/ehz405.
11. 11. Marcus JT, Gan CT, Zwanenburg JJ, et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008;51:750-757.
12. 12. Mauritz GJ, Marcus JT, Westerhof N, Postmus PE, Vonk-Noordegraaf A. Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart 2011;97:473-478.
13. 13. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998;97:1946-1951.
14. 14. Harjola VP, Mebazaa A, Celutkiene J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 2016;18:226-241.
15. 15. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991;100:598.
16. 16. Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry. J Am Coll Cardiol 2011;57:700-706.
17. 17. Ammar H, Ohri C, Hajouli S, et al. Prevalence and Predictors of Pulmonary Embolism in Hospitalized Patients with Syncope. South med J 2019;112(8):421-427. DOI:10.14423/SMJ.0000000000001009.
18. 18. Rodger MA, Carrier M, Jones GN, et al. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am J Respir Crit Care Med 2000;162:2105-2108.Stein PD, Goldhaber SZ, Henry JW. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 1995;107:139.
19. 19. Stein PD, Goldhaber SZ, Henry JW. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 1995;107:139.
20. 20. Kline JA, Hernandez-Nino J, Newgard CD, et al. Use of pulse oximetry to predict in-hospital complications in normotensive patients with pulmonary embolism. Am J Med 2003;115:203.
21. 21. Co I, Eilbert W, Chiganos T. New Electrocardiographic Changes In Patients Diagnosed With Pulmonary Embolism. J Emerg Med 2017;52(3):280-285. DOI: 10.1016/j.jemermed.2016.09.009.
22. 22. Shopp JD, Stewart LK, Emmett TW, Kline JA. Findings From 12-lead Electrocardiography That Predict Circulatory Shock From Pulmonary Embolism: Systematic Review and Meta-analysis. Acad Emerg Med 2015; 22:1127.
23. 23. Electrocardiographic findings in pulmonary embolism Elaine Boey1, MBBS, MRCP, Swee-Guan Teo2, MRCP, FACC, Kian-Keong Poh1,3, FRCP, FACC Singapore Med J 2015; 56(10): 533-537doi: 10.11622/smedj.2015147.
24. 24. Prandoni P, Lensing AW, Prins MH, et al. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med 2016;375:1524-1531.
25. 25. Karalezli A. Pulmoner Emboli. Güncel Göğüs Hastalıkları Serisi 2018;6 (2): 16-35.
26. 26. Jan neke M. T. Hendriksen, Wim A. M. Lucassen, Petra M. G. Erkens, et al. Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of “Gestalt” and the Wells Rule. Ann Fam Med 2016;14:227-234. DOI: 10.1370/afm.1930.84.
27. 27. Sanders S, Doust J, Glasziou P. A systematic review of studies comparing diagnostic clinical prediction rules with clinical judgment. PLoS One 2015;10:e0128233.
28. 28. Penaloza A, Verschuren F, Meyer G, et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med 2013;62:117-124.
29. 29. Wells PS, Anderson DR, Rodger M, et al.Derivation simple clinical model to categorize patients probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thromb Haemost 2000 Mar;83(3):416-20.
30. 30. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144: 165-71.
31. 31. Ceriani E, Combescure C, Le Gal G, et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost 2010;8:957-970.
32. 32. Kline JA, Webb WB, Jones AE, Hernandez-Nino J. Impact of a rapid rule-out protocol for pulmonary embolism on the rate of screening, missed cases, and pulmonary vascular imaging in an urban US emergency department. Ann Emerg Med 2004;44:490-502.
33. 33. Malavolta D, Quatela V, Moffat J, Ottolini BB. Effect of the Pulmonary Embolism Rule Out Criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial. Intern Emerg Med 2019;14:309–310. https://doi.org/10.1007/s11739-019-02027-1.
34. 34. Lucassen W, Geersing GJ, Erkens PM, et al. Clinical decision rules for excluding pulmonary embolism: a meta-analysis. Ann Intern Med 2011;155:448.
35. 35. Kline JA, Courtney DM, Kabrhel C, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 2008;6:772-80.
36. 36. Corrigan D, Prucnal C, Kabrhel C. Pulmonary embolism: the diagnosis, risk-stratification, treatment, and disposition of emergency department patients. Exp Emerg Med 2016;3(3):117-125. http://dx.doi.org/10.15441/ceem.16.146
37. 37. Righini M, Le Gal G, De Lucia S, et al. Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost 2006;95:715-719.
38. 38. Carrier M, Righini M, Djurabi RK, et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb Haemost 2009;101:886-892.
39. 39. Tom van der Hulle, Whitney Y Cheung, Stephanie Kooij, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017;390(10091):289-297. DOI: 10.1016/S0140-6736(17)30885-1.
40. 40. Righini M, Van Es J, Den Exter PL, et al. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism The ADJUST-PE Study. JAMA. 2014;311(11):1117-1124. DOI:10.1001/jama.2014.2135,
41. 41. Coutance G, Cauderlier E, Ehtisham J, Hamon M, Hamon M. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 2011;15:R103.
42. 42. Bajaj A, Saleeb M, Rathor P, Sehgal V, Kabak B, Hosur S. Prognostic value of troponins in acute nonmassive pulmonary embolism: a meta-analysis. Heart Lung 2015;44:327-334.
43. 43. Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010;8:1716-1722.
44. 44. Stein PD, Fowler SE, Goodman LR, et al. PIOPED II Investigators. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006;354:2317-2327.
45. 45. Im DJ, Hur J, Han KH, et al. Acute pulmonary embolism: a retrospective cohort study of the predictive value of perfusion defect volume measured with dual-energy CT. AJR Am J Roentgenol 2017;209:1015-22.
46. 46. Mastora I, Remy-Jardin M, Masson P, et al. Severity of acute pulmonary embolism: evaluation of a new spiral CT angiographic score in correlation with echocardiographic data. Eur Radiol 2003;13:29-35.
47. 47. Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Ann ICRP 2015;44:7-321.18.
48. 48. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 2007;298:317-23.
49. 49. Sostman HD, Stein PD, Gottschalk A, Matta F, Hull R, Goodman L. Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology 2008;246(3):941-6.
50. 50. Parker JA, Coleman RE, Grady E, et al. SNM Practice Guideline for Lung Scintigraphy 4.0 J Nucl Med Technol. 2012;40(1):57-65.
51. 51. Alastair J. E. Moore, Jason Wachsmann, Murthy R. Chamarthy, Lloyd Panjikaran, Yuki Tanabe, Prabhakar Rajiah. Imaging of acute pulmonary embolism: an update Cardiovasc Diagn Ther 2018;8(3):225-243. DOI: 10.21037/cdt.2017.12.01.
52. 52. Reinartz P, Wildberger JE, Schaefer W, et al. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med 2004;45:1501-8.
53. 53. Stein PD, Sostman HD, Dalen JE, et al. Consensus Group. Controversies in diagnosis of pulmonary embolism. Clin Appl Thromb Hemost 2011;17:140-149.
54. 54. Qanadli SD, Hajjam ME, Mesurolle B, et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000;217:447-455.
55. 55. Revel MP, Sanchez O, Couchon S, et al. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the ‘IRM-EP’ study. J Thromb Haemost 2012;10:743-750.
56. 56. Kurnicka K, Lichodziejewska B, Goliszek S, et al. Echocardiographic pattern of acute pulmonary embolism: analysis of 511 consecutive patients. J Am Soc Echocardiogr 2016;29:907-913.
57. 57. Casazza F, Bongarzoni A, Capozi A, Agostoni O. Regional right ventricular dysfunction in acute pulmonary embolism and right ventricular infarction. Eur J Echocardiogr 2005;6:11-4.
58. 58. Dahhan T, Siddiqui I, Tapson VF, et al. Clinical and echocardiographic predictors of mortality in acute pulmonary embolism. Cardiovascular Ultrasound 2016;14:44. DOI 10.1186/s12947-016-0087-y.
59. 59. Dresden S, Mitchell P, Rahimi L, et al. Right ventricular dilatation on bedside echocardiography performed by emergency physicians aids in the diagnosis of pulmonary embolism. Ann Emerg Med 2014;63:16-24.
60. 60. Perrier A, Bounameaux H. Ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1998;128:243-243.
61. 61. Le Gal G, Righini M, Sanchez O, et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006;95:963-966.
62. 62. Pruszczyk P, Goliszek S, Lichodziejewska B, et al. Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging 2014;7:553_-60.
63. 63. Bikdeli B, Lobo JL, Jimenez D, et al. Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry. J Am Heart Assoc. 2018;7: e009042. DOI: 10.1161/JAHA.118.009042.
64. 64. S. Vanni, G. Viviani, G. Pepe, P. Nazerian, S. Grifoni, et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thromboembolism lactate outcome study, Ann. Emerg. Med. 2013;61 (3):330–338.
65. 65. Wyzgal A, Koc M, Pacho S, et al. Plasma copeptin for short term risk stratification in acute pulmonary embolism. J Thromb Thrombolysis 2016;41:563-568.
66. 66. Dellas C, Tschepe M, Seeber V, et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost 2014;111:996-1003.
67. 67. Hobohm L, Hellenkamp K, Hasenfuss G, Munzel T, Konstantinides S, Lankeit M. Comparison of risk assessment strategies for not-high-risk pulmonary embolism. Eur Respir J 2016;47:1170-1178.
68. 68. Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J 2014;44: 694-703. DOI: 10.1183/09031936.00006114.
69. 69. Jime´nez D, Aujesky D, Moores L, et al. Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism. Arch Intern Med. 2010;170(15):1383-1389.
70. 70. Aissaoui N, Konstantinides S, Meyer G. What’s new in severe pulmonary embolism? Intensive Care Med (2019) 45:75–77 https://doi.org/10.1007/s00134-018-5199-4.
71. 71. Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of Pulmonary Embolism. JACC 2016;67:976-90.
72. 72. Righini M, Aujesky D, Roy PM, et al. Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism. Arch Intern Med 2004;164:2483-2487.
73. 73. Perrier A, Miron MJ, Desmarais S, et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: is it a valid option in patients with normal results of lower-limb venous compression ultrasonography? Arch Intern Med 2000;160:512-516.
74. 74. Burrowes KS, Clark AR, Tawhai MH. Blood flow redistribution and ventilation perfusion mismatch during embolic pulmonary arterial occlusion. Pulm Circ 2011;1:365-376.
75. 75. Messika J, Goutorbe P, Hajage D, Ricard JD. Severe pulmonary embolism managed with high-flow nasal cannula oxygen therapy. Eur J Emerg Med 2017;24:230-232.
76. 76. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 1999;27:540-544.
77. 77. Green EM, Givertz MM. Management of acute right ventricular failure in the intensive care unit. Curr Heart Fail Rep 2012;9:228-235.
78. 78. Yamamoto T. Management of patients with high-risk pulmonary embolism: A narrative review. J Intensive Care 2018;6:16.
79. 79. Elder M, Blank N, Shemesh A, et al. Mechanical Circulatory Support for High-Risk Pulmonary Embolism. Intervent Cardiol Clin 2018;7:119-128.
80. 80. Perkins GD, Olasveengen TM, Maconochie I, Soar J, Wyllie J, Greif R, Lockey A, Semeraro F, Van de Voorde P, Lott C, Monsieurs KG, Nolan JP; European Resuscitation Council. European Resuscitation Council Guidelines for Resuscitation: 2017 update. Resuscitation 2018;123:43-50.
81. 81. Erkens PM, Prins MH. Fixed-dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.Cochrane Database Syst Rev 2010;9:CD001100.
82. 82. Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, Meyer G, Perrier A. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015;36:605-614.
83. 83. Meneveau N, Séronde MF, Blonde MC et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest. 2006;129(4):1043-50.
84. 84. Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015;36:605-614.
85. 85. Meyer G, Vicaut E, Danays T, et al.; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402-1411.
86. 86. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M; MOPETT Investigators. Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol 2013;111:273-277.
87. 87. Wang C, Zhai Z, Yang Y, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest 2010;137:254-262.
88. 88. Kucher N, Boekstegers P, Müuller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014;129:479-86.
89. 89. Lee T, Itagaki S, Chiang YP, Egorova NN, Adams DH, Chikwe J. Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013. J Thorac Cardiovasc Surg 2018;155:1084-1090.
90. 90. Den Exter PL, Zondag W, Klok FA, et al. Vesta Study Investigators.Efficacy and safety of outpatient treatment based on the Hestia clinical decision rule with or without NT-proBNP testing in patients with acute pulmonary embolism: a randomized clinical trial. Am J Respir Crit Care Med 2016;194:998-1006.
91. 91. Roy PM, Moumneh T, Penaloza A, Sanchez O. Outpatient management of pulmonary embolism. Thromb Res 2017;155:92-100.
92. 92. Zondag W, Mos IC, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011;9:1500-1507.
93. 93. Righini M, Robert-Ebadi H, Elias A, et al.; CT-PE-Pregnancy Group. Diagnosis of pulmonary embolism during pregnancy: a multicenter prospective management outcome study. Ann Intern Med 2018;169:766-773.
94. 94. Righini M, Robert-Ebadi H, Elias A, et al. Diagnosis of Pulmonary Embolism During Pregnancy A Multicenter Prospective Management Outcome Study. Ann Intern Med. 2018;4;169(11):766-773. DOI: 10.7326/M18-1670.
95. 95. van der Pol LM, Tromeur C, Bistervels IM, et al. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med. 2019;21;380(12):1139-1149. DOI: 10.1056/NEJMoa1813865.
96. 96. Shahir K, McCrea JM, Lozano LA, Goodman LR. Reduced z-axis technique for CT pulmonary angiography in pregnancy–validation for practical use and dose reduction. Emerg Radiol 2015;22:651656.
97. 97. Stein PD, Chenevert TL, Fowler SE, et al.; PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis II) Investigators. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010;152:434-443.
98. 98. Sheen JJ, Haramati LB, Natenzon A, et al. Performance of low-dose perfusion scintigraphy and CT pulmonary angiography for pulmonary embolism in pregnancy. Chest 2018;153:152-160.
99. 99. Righini M, Robert-Ebadi H, Elias A, et al.; CT-PE-Pregnancy Group. Diagnosis of pulmonary embolism during pregnancy: a multicenter prospective management outcome study. Ann Intern Med 2018;169:766-773.
100. 100. Martillotti G, Boehlen F, Robert-Ebadi H, Jastrow N, Righini M, Blondon M. Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost 2017;15:1942-1.